United States Biotechnology & Medical Research

Cue Biopharma Inc (CUE)

Track

Track

Cue Biopharma Inc. experienced significant insider trading activity recently, with executives offloading over $2 million in shares during August 2026. These sales occurred alongside a challenging earnings report. Despite an 11.4% stock price increase over the last quarter, leadership liquidated positions, reflecting a net negative insider sentiment across fourteen recorded transactions.
Ticker: CUE Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cue Biopharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Ray Sumita Chief Legal Compliance Officer Officer
Transaction date
Sale
Price
208.27
Quantity 49,950 +41.4%
Value US$1,823,158
Ray Sumita Chief Legal Compliance Officer Officer
Transaction date
Sale
Price
476.20
Quantity 60,292 +12.8%
Value US$2,812,024
Ray Sumita Chief Legal Compliance Officer Officer
Transaction date
Sale
Price
306.58
Quantity 96,672 -21.7%
Value US$2,088,315
Meluzio Michael Vincent VP, Prin. Accounting Officer Officer
Transaction date
Sale
Price
31.13
Quantity 3 -0.0%
Value US$93
Meluzio Michael Vincent VP, Prin. Accounting Officer Officer
Transaction date
Sale
Price
30.35
Quantity 4,106 -7.7%
Value US$124,617
Meluzio Michael Vincent VP, Prin. Accounting Officer Officer
Transaction date
Sale
Price
29.37
Quantity 1,519 -2.8%
Value US$44,613
3.1
Lin Shao-Lee Chief Executive Officer Executive Director
Transaction date
Sale
Price
29.48
Quantity 10,460 -1.5%
Value US$308,361
3.1
Lin Shao-Lee Chief Executive Officer Executive Director
Transaction date
Sale
Price
28.11
Quantity 2,375 -0.3%
Value US$66,761
3.1
Lin Shao-Lee Chief Executive Officer Executive Director
Transaction date
Sale
Price
27.19
Quantity 5,423 -0.7%
Value US$147,451
3.1
Shao-Lee Lin Officer; Director Executive Director
Transaction date
Proposed sale
Price
28.26
Quantity 18,258
Value US$515,971
Sumita Ray Officer; CORPORATE SECRETARY Officer
Transaction date
Proposed sale
Price
30.14
Quantity 8,829
Value US$266,106
3.1
Lin Shao-Lee Chief Executive Officer Executive Director
Transaction date
Sale
Price
27.75
Quantity 5,775 -0.8%
Value US$160,256
3.1
Lin Shao-Lee Chief Executive Officer Executive Director
Transaction date
Sale
Price
26.99
Quantity 34,225 -4.5%
Value US$923,733
3.1
Shao-Lee Lin Officer; Director Executive Director
Transaction date
Proposed sale
Price
27.01
Quantity 40,000
Value US$1,080,400
2.4
Sarraf Pasha Non-Executive Director
Transaction date
Purchase
Price
0.30
Quantity 77,417 +31.4%
Value US$23,349
2.4
Sarraf Pasha Non-Executive Director
Transaction date
Purchase
Price
0.31
Quantity 78,116 +46.4%
Value US$24,325
2.4
Sarraf Pasha Non-Executive Director
Transaction date
Purchase
Price
0.32
Quantity 86,947 +106.8%
Value US$27,597
2.4
Sarraf Pasha Non-Executive Director
Transaction date
Purchase
Price
0.30
Quantity 77,148 +1824.3%
Value US$23,168
2.4
Sarraf Pasha Non-Executive Director
Transaction date
Purchase
Price
0.31
Quantity 4,229 +inf%
Value US$1,308
MATTEO GIACOMO LEVISETTI Officer Officer
Transaction date
Proposed sale
Price
0.26
Quantity 7,230
Value US$1,907
2.5
PASSERI DANIEL R CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
1.03
Quantity 30,000 +22.3%
Value US$30,900
1.4
Suri Anish PRESIDENT AND CSO Officer
Transaction date
Purchase
Price
2.76
Quantity 4,000 +3.0%
Value US$11,040
2.5
PASSERI DANIEL R CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.86
Quantity 3,000 +2.3%
Value US$8,580
0.6
Kiener Peter A Non-Executive Director
Transaction date
Sale
Price
3.28
Quantity 9,325 -96.3%
Value US$30,586
0.6
Morich Frank Non-Executive Director
Transaction date
Purchase
Price
3.75
Quantity 28,000 +inf%
Value US$105,000
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
3.34
Quantity 55,000 +6.2%
Value US$183,700
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
3.52
Quantity 150,000 +20.4%
Value US$528,000
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
4.76
Quantity 735,000 +inf%
Value US$3,498,600
0.6
Kiener Peter A Non-Executive Director
Transaction date
Planned sale
Price
18.02
Quantity 1,361 -100.0%
Value US$24,525
0.6
Kiener Peter A Non-Executive Director
Transaction date
Planned sale
Price
17.92
Quantity 18,815 -100.0%
Value US$337,165
1.4
Suri Anish President and CSO Officer
Transaction date
Planned sale
Price
18.05
Quantity 8,000 -7.8%
Value US$144,400
1.4
Suri Anish President and CSO Officer
Transaction date
Planned sale
Price
15.07
Quantity 20,000 -17.5%
Value US$301,354
Millar Kerri-Ann CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
14.21
Quantity 1,251 -10.7%
Value US$17,783
2.5
PASSERI DANIEL R CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
14.72
Quantity 3,400 +6.5%
Value US$50,051
1.4
Suri Anish PRESIDENT AND CSO Officer
Transaction date
Planned sale
Price
15.23
Quantity 20,000 -21.1%
Value US$304,646
0.8
Pienta Kenneth Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.09
Quantity 439 -18.0%
Value US$6,626
0.8
Pienta Kenneth Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.10
Quantity 13,000 -86.7%
Value US$196,269
0.8
Pienta Kenneth Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.06
Quantity 4,274 -68.1%
Value US$64,345
0.8
Pienta Kenneth Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.15
Quantity 16,000 -88.9%
Value US$242,422
0.8
Pienta Kenneth Chief Medical Officer Officer
Transaction date
Purchase
Price
15.07
Quantity 2,720 +136.0%
Value US$40,980
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
12.64
Quantity 6,548 +4.1%
Value US$82,776
1.0
Gray Cameron Non-Executive Director
Transaction date
Purchase
Price
15.30
Quantity 5,000 +0.7%
Value US$76,500
1.0
Gray Cameron Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 5,000 +0.7%
Value US$75,000
2.0
Sandercock Colin SVP, General Counsel and Sec Officer
Transaction date
Planned sale
Price
20.00
Quantity 13,274 -43.7%
Value US$265,480
1.4
Suri Anish President and CSO Officer
Transaction date
Planned sale
Price
20.01
Quantity 800 -2.3%
Value US$16,008
1.4
Suri Anish President and CSO Officer
Transaction date
Planned sale
Price
20.14
Quantity 400 -1.1%
Value US$8,056
2.0
Sandercock Colin SVP, General Counsel and Sec Officer
Transaction date
Planned sale
Price
20.05
Quantity 201 -1.2%
Value US$4,030
1.4
Suri Anish President and CSO Officer
Transaction date
Planned sale
Price
20.01
Quantity 5,800 -14.4%
Value US$116,058
2.0
Sandercock Colin SVP, General Counsel and Sec Officer
Transaction date
Planned sale
Price
20.00
Quantity 6,425 -27.3%
Value US$128,500
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
25.24
Quantity 2,953 +1.9%
Value US$74,534
2.7
Fletcher Aaron G.L. Non-Executive Director
Transaction date
Purchase
Price
24.64
Quantity 4,547 +3.0%
Value US$112,038
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Sale
Price
15.71
Quantity 9,000 -100.0%
Value US$141,390
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Sale
Price
15.77
Quantity 6,700 -0.9%
Value US$105,659
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Sale
Price
17.24
Quantity 9,000 -1.1%
Value US$155,160
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Sale
Price
17.53
Quantity 19,647 -2.4%
Value US$344,412
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Sale
Price
16.82
Quantity 17,000 -2.1%
Value US$285,940
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Sale
Price
17.00
Quantity 4,000 -0.5%
Value US$68,000
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Sale
Price
15.73
Quantity 20,732 -2.5%
Value US$326,114
2.5
PASSERI DANIEL R CEO and President Executive Director
Transaction date
Purchase
Price
7.26
Quantity 1,377 +2.7%
Value US$9,997
2.0
Sandercock Colin SVP, General Counsel and Sec
Transaction date
Purchase
Price
7.93
Quantity 14,938 +746.9%
Value US$118,458
2.0
Sandercock Colin SVP, General Counsel and Sec
Transaction date
Purchase
Price
7.10
Quantity 2,000 +inf%
Value US$14,200
2.5
PASSERI DANIEL R CEO and President Executive Director
Transaction date
Purchase
Price
6.90
Quantity 3,000 +6.3%
Value US$20,700
3.8
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Purchase
Price
4.64
Quantity 18,521 +26.1%
Value US$85,937
3.4
DIGIANDOMENICO ANTHONY Non-Executive Director
Transaction date
Purchase
Price
4.62
Quantity 7,000 +14.0%
Value US$32,340
DIGIANDOMENICO ANTHONY Non-Executive Director
Transaction date
Purchase
Price
4.77
Quantity 20,000 +66.7%
Value US$95,400
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Purchase
Price
4.29
Quantity 19,647 +38.2%
Value US$84,286
3.4
DIGIANDOMENICO ANTHONY Non-Executive Director
Transaction date
Purchase
Price
4.81
Quantity 10,000 +50.0%
Value US$48,100
Suri Anish Chief Scientific Officer Officer
Transaction date
Purchase
Price
4.37
Quantity 2,000 +inf%
Value US$8,740
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Purchase
Price
4.53
Quantity 17,200 +50.2%
Value US$77,916
DIGIANDOMENICO ANTHONY Non-Executive Director
Transaction date
Purchase
Price
4.49
Quantity 10,000 +100.0%
Value US$44,900
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Purchase
Price
4.74
Quantity 9,438 +38.1%
Value US$44,736
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 400 +1.6%
Value US$2,000
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Purchase
Price
5.20
Quantity 3,664 +17.7%
Value US$19,053
DIGIANDOMENICO ANTHONY Non-Executive Director
Transaction date
Purchase
Price
5.48
Quantity 10,000 +inf%
Value US$54,800
MARLETT CHRISTOPHER A Non-Executive Director
Transaction date
Purchase
Price
5.06
Quantity 10,000 +93.2%
Value US$50,600
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-17 2026-08-13 S Sale
Ray Sumita

Chief Legal Compliance Officer

Officer
49,950 +41.4%
208.27
US$1,823,158 		49,950 +41.4% 208.27 US$1,823,158
2026-08-17 2026-08-13 S Sale
Ray Sumita

Chief Legal Compliance Officer

Officer
60,292 +12.8%
476.20
US$2,812,024 		60,292 +12.8% 476.20 US$2,812,024
2026-08-17 2026-08-13 S Sale
Ray Sumita

Chief Legal Compliance Officer

Officer
96,672 -21.7%
306.58
US$2,088,315 		96,672 -21.7% 306.58 US$2,088,315
2026-08-17 2026-08-13 S Sale
Meluzio Michael Vincent

VP, Prin. Accounting Officer

Officer
3 -0.0%
31.13
US$93 		3 -0.0% 31.13 US$93
2026-08-17 2026-08-13 S Sale
Meluzio Michael Vincent

VP, Prin. Accounting Officer

Officer
4,106 -7.7%
30.35
US$124,617 		4,106 -7.7% 30.35 US$124,617
2026-08-17 2026-08-13 S Sale
Meluzio Michael Vincent

VP, Prin. Accounting Officer

Officer
1,519 -2.8%
29.37
US$44,613 		1,519 -2.8% 29.37 US$44,613
2026-08-14 2026-08-13 S Sale
3.1
Lin Shao-Lee

Chief Executive Officer

Executive Director
10,460 -1.5%
29.48
US$308,361 		10,460 -1.5% 29.48 US$308,361
2026-08-14 2026-08-13 S Sale
3.1
Lin Shao-Lee

Chief Executive Officer

Executive Director
2,375 -0.3%
28.11
US$66,761 		2,375 -0.3% 28.11 US$66,761
2026-08-14 2026-08-13 S Sale
3.1
Lin Shao-Lee

Chief Executive Officer

Executive Director
5,423 -0.7%
27.19
US$147,451 		5,423 -0.7% 27.19 US$147,451
2026-08-14 2026-08-13 PrS Proposed sale
3.1
Shao-Lee Lin

Officer; Director

Executive Director
18,258
28.26
US$515,971 		18,258 28.26 US$515,971
2026-08-13 2026-08-13 PrS Proposed sale
Sumita Ray

Officer; CORPORATE SECRETARY

Officer
8,829
30.14
US$266,106 		8,829 30.14 US$266,106
2026-08-14 2026-08-12 S Sale
3.1
Lin Shao-Lee

Chief Executive Officer

Executive Director
5,775 -0.8%
27.75
US$160,256 		5,775 -0.8% 27.75 US$160,256
2026-08-14 2026-08-12 S Sale
3.1
Lin Shao-Lee

Chief Executive Officer

Executive Director
34,225 -4.5%
26.99
US$923,733 		34,225 -4.5% 26.99 US$923,733
2026-08-14 2026-08-12 PrS Proposed sale
3.1
Shao-Lee Lin

Officer; Director

Executive Director
40,000
27.01
US$1,080,400 		40,000 27.01 US$1,080,400
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
77,417 +31.4%
0.30
US$23,349 		77,417 +31.4% 0.30 US$23,349
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
78,116 +46.4%
0.31
US$24,325 		78,116 +46.4% 0.31 US$24,325
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
86,947 +106.8%
0.32
US$27,597 		86,947 +106.8% 0.32 US$27,597
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
77,148 +1824.3%
0.30
US$23,168 		77,148 +1824.3% 0.30 US$23,168
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
4,229 +inf%
0.31
US$1,308 		4,229 +inf% 0.31 US$1,308
2025-12-29 2025-12-29 PrS Proposed sale
MATTEO GIACOMO LEVISETTI

Officer

Officer
7,230
0.26
US$1,907 		7,230 0.26 US$1,907
2024-12-18 2024-12-16 B Purchase
2.5
PASSERI DANIEL R

CHIEF EXECUTIVE OFFICER

Executive Director
30,000 +22.3%
1.03
US$30,900 		30,000 +22.3% 1.03 US$30,900
2023-08-29 2023-08-25 B Purchase
1.4
Suri Anish

PRESIDENT AND CSO

Officer
4,000 +3.0%
2.76
US$11,040 		4,000 +3.0% 2.76 US$11,040
2023-08-16 2023-08-14 B Purchase
2.5
PASSERI DANIEL R

CHIEF EXECUTIVE OFFICER

Executive Director
3,000 +2.3%
2.86
US$8,580 		3,000 +2.3% 2.86 US$8,580
2023-03-27 2023-03-23 S Sale
0.6
Kiener Peter A
Non-Executive Director
9,325 -96.3%
3.28
US$30,586 		9,325 -96.3% 3.28 US$30,586
2022-05-31 2022-05-27 B Purchase
0.6
Morich Frank
Non-Executive Director
28,000 +inf%
3.75
US$105,000 		28,000 +inf% 3.75 US$105,000
2022-05-25 2022-05-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
55,000 +6.2%
3.34
US$183,700 		55,000 +6.2% 3.34 US$183,700
2022-05-25 2022-05-23 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
150,000 +20.4%
3.52
US$528,000 		150,000 +20.4% 3.52 US$528,000
2022-04-04 2022-03-31 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
735,000 +inf%
4.76
US$3,498,600 		735,000 +inf% 4.76 US$3,498,600
2021-11-17 2021-11-16 PlS Planned sale
0.6
Kiener Peter A
Non-Executive Director
1,361 -100.0%
18.02
US$24,525 		1,361 -100.0% 18.02 US$24,525
2021-11-17 2021-11-15 PlS Planned sale
0.6
Kiener Peter A
Non-Executive Director
18,815 -100.0%
17.92
US$337,165 		18,815 -100.0% 17.92 US$337,165
2021-11-17 2021-11-15 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
8,000 -7.8%
18.05
US$144,400 		8,000 -7.8% 18.05 US$144,400
2021-11-15 2021-11-11 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
20,000 -17.5%
15.07
US$301,354 		20,000 -17.5% 15.07 US$301,354
2021-10-05 2021-10-01 PlS Planned sale
Millar Kerri-Ann

CHIEF FINANCIAL OFFICER

Officer
1,251 -10.7%
14.21
US$17,783 		1,251 -10.7% 14.21 US$17,783
2021-09-27 2021-09-24 B Purchase
2.5
PASSERI DANIEL R

CHIEF EXECUTIVE OFFICER

Executive Director
3,400 +6.5%
14.72
US$50,051 		3,400 +6.5% 14.72 US$50,051
2021-09-27 2021-09-23 PlS Planned sale
1.4
Suri Anish

PRESIDENT AND CSO

Officer
20,000 -21.1%
15.23
US$304,646 		20,000 -21.1% 15.23 US$304,646
2021-03-17 2021-03-16 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
439 -18.0%
15.09
US$6,626 		439 -18.0% 15.09 US$6,626
2021-03-17 2021-03-15 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
13,000 -86.7%
15.10
US$196,269 		13,000 -86.7% 15.10 US$196,269
2021-02-18 2021-02-17 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
4,274 -68.1%
15.06
US$64,345 		4,274 -68.1% 15.06 US$64,345
2021-02-18 2021-02-16 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
16,000 -88.9%
15.15
US$242,422 		16,000 -88.9% 15.15 US$242,422
2021-01-22 2021-01-20 B Purchase
0.8
Pienta Kenneth

Chief Medical Officer

Officer
2,720 +136.0%
15.07
US$40,980 		2,720 +136.0% 15.07 US$40,980
2020-11-25 2020-11-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
6,548 +4.1%
12.64
US$82,776 		6,548 +4.1% 12.64 US$82,776
2020-10-01 2020-09-30 B Purchase
1.0
Gray Cameron
Non-Executive Director
5,000 +0.7%
15.30
US$76,500 		5,000 +0.7% 15.30 US$76,500
2020-10-01 2020-09-29 B Purchase
1.0
Gray Cameron
Non-Executive Director
5,000 +0.7%
15.00
US$75,000 		5,000 +0.7% 15.00 US$75,000
2020-08-07 2020-08-05 PlS Planned sale
2.0
Sandercock Colin

SVP, General Counsel and Sec

Officer
13,274 -43.7%
20.00
US$265,480 		13,274 -43.7% 20.00 US$265,480
2020-08-07 2020-08-05 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
800 -2.3%
20.01
US$16,008 		800 -2.3% 20.01 US$16,008
2020-08-05 2020-08-04 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
400 -1.1%
20.14
US$8,056 		400 -1.1% 20.14 US$8,056
2020-08-05 2020-08-04 PlS Planned sale
2.0
Sandercock Colin

SVP, General Counsel and Sec

Officer
201 -1.2%
20.05
US$4,030 		201 -1.2% 20.05 US$4,030
2020-08-05 2020-08-03 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
5,800 -14.4%
20.01
US$116,058 		5,800 -14.4% 20.01 US$116,058
2020-08-05 2020-08-03 PlS Planned sale
2.0
Sandercock Colin

SVP, General Counsel and Sec

Officer
6,425 -27.3%
20.00
US$128,500 		6,425 -27.3% 20.00 US$128,500
2020-06-25 2020-06-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
2,953 +1.9%
25.24
US$74,534 		2,953 +1.9% 25.24 US$74,534
2020-06-25 2020-06-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
4,547 +3.0%
24.64
US$112,038 		4,547 +3.0% 24.64 US$112,038
2019-12-31 2019-12-31 S Sale MARLETT CHRISTOPHER A Non-Executive Director
9,000 -100.0%
15.71
US$141,390 		9,000 -100.0% 15.71 US$141,390
2019-12-31 2019-12-31 S Sale MARLETT CHRISTOPHER A Non-Executive Director
6,700 -0.9%
15.77
US$105,659 		6,700 -0.9% 15.77 US$105,659
2019-12-31 2019-12-27 S Sale MARLETT CHRISTOPHER A Non-Executive Director
9,000 -1.1%
17.24
US$155,160 		9,000 -1.1% 17.24 US$155,160
2019-12-27 2019-12-26 S Sale MARLETT CHRISTOPHER A Non-Executive Director
19,647 -2.4%
17.53
US$344,412 		19,647 -2.4% 17.53 US$344,412
2019-12-27 2019-12-23 S Sale MARLETT CHRISTOPHER A Non-Executive Director
17,000 -2.1%
16.82
US$285,940 		17,000 -2.1% 16.82 US$285,940
2019-12-19 2019-12-19 S Sale MARLETT CHRISTOPHER A Non-Executive Director
4,000 -0.5%
17.00
US$68,000 		4,000 -0.5% 17.00 US$68,000
2019-12-19 2019-12-17 S Sale MARLETT CHRISTOPHER A Non-Executive Director
20,732 -2.5%
15.73
US$326,114 		20,732 -2.5% 15.73 US$326,114
2019-06-25 2019-06-21 B Purchase
2.5
PASSERI DANIEL R

CEO and President

Executive Director
1,377 +2.7%
7.26
US$9,997 		1,377 +2.7% 7.26 US$9,997
2019-06-10 2019-06-10 B Purchase
2.0
Sandercock Colin

SVP, General Counsel and Sec
14,938 +746.9%
7.93
US$118,458 		14,938 +746.9% 7.93 US$118,458
2019-06-10 2019-06-06 B Purchase
2.0
Sandercock Colin

SVP, General Counsel and Sec
2,000 +inf%
7.10
US$14,200 		2,000 +inf% 7.10 US$14,200
2019-06-07 2019-06-06 B Purchase
2.5
PASSERI DANIEL R

CEO and President

Executive Director
3,000 +6.3%
6.90
US$20,700 		3,000 +6.3% 6.90 US$20,700
2019-01-02 2018-12-31 B Purchase
3.8
MARLETT CHRISTOPHER A
Non-Executive Director
18,521 +26.1%
4.64
US$85,937 		18,521 +26.1% 4.64 US$85,937
2019-01-02 2018-12-28 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
7,000 +14.0%
4.62
US$32,340 		7,000 +14.0% 4.62 US$32,340
2018-12-28 2018-12-27 B Purchase DIGIANDOMENICO ANTHONY Non-Executive Director
20,000 +66.7%
4.77
US$95,400 		20,000 +66.7% 4.77 US$95,400
2018-12-27 2018-12-26 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
19,647 +38.2%
4.29
US$84,286 		19,647 +38.2% 4.29 US$84,286
2019-01-04 2018-12-24 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
10,000 +50.0%
4.81
US$48,100 		10,000 +50.0% 4.81 US$48,100
2018-12-26 2018-12-21 B Purchase Suri Anish

Chief Scientific Officer

Officer
2,000 +inf%
4.37
US$8,740 		2,000 +inf% 4.37 US$8,740
2018-12-26 2018-12-21 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
17,200 +50.2%
4.53
US$77,916 		17,200 +50.2% 4.53 US$77,916
2018-12-26 2018-12-21 B Purchase DIGIANDOMENICO ANTHONY Non-Executive Director
10,000 +100.0%
4.49
US$44,900 		10,000 +100.0% 4.49 US$44,900
2018-12-21 2018-12-20 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
9,438 +38.1%
4.74
US$44,736 		9,438 +38.1% 4.74 US$44,736
2018-12-20 2018-12-19 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
400 +1.6%
5.00
US$2,000 		400 +1.6% 5.00 US$2,000
2018-12-19 2018-12-18 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
3,664 +17.7%
5.20
US$19,053 		3,664 +17.7% 5.20 US$19,053
2018-12-18 2018-12-17 B Purchase DIGIANDOMENICO ANTHONY Non-Executive Director
10,000 +inf%
5.48
US$54,800 		10,000 +inf% 5.48 US$54,800
2018-12-17 2018-12-13 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
10,000 +93.2%
5.06
US$50,600 		10,000 +93.2% 5.06 US$50,600
Explore more

More insider trading research around Cue Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America